Slides and webcasts from ESMO World Congress on Gastrointestinal Cancer 2018 are open to all!
New ESMO Clinical Practice Guidelines now online: Delirium in adult cancer patients
Haven't had much time lately? Here's what you may have missed in the last few months.
Sign-up to receive the OncologyPRO alert every 2 weeks.
E-Learning: ESMO E-Learning: Advances in Hepatobiliary Cancers, by Juan W. Valle
17 Jul 2018
Urinary and sexual outcomes 2 years after radical prostatectomy for prostate cancer are comparable with robot-assisted laparoscopic and open retropubic...
16 Jul 2018
Node-negative breast cancer patients in the USA may be overtreated as not all surgeons are following advice on when axillary lymph node dissection is...
13 Jul 2018
Late recurrence and mild symptoms predict a better than might be expected outcome for patients with head and neck cancer
12 Jul 2018
Phase I study findings suggest thermosensitive liposomes may be able to deliver doxorubicin to inoperable liver tumours
11 Jul 2018
Study suggests almost a fifth of men with metastatic castration-resistant prostate cancer may develop treatment-emergent small-cell neuroendocrine...
Thierry Conroy reporting from ASCO 2018 describes the design and key results of the trial that compared adjuvant modified (m) FOLFIRINOX regimen with standard gemcitabine in patients with resected pancreatic cancer.
20-23 Jun 2018, Barcelona, Spain
15-20 Jun 2018, Belgrade, Serbia
22-23 May 2018, Zurich, Switzerland
18-19 May 2018, Valencia, Spain
11-12 May 2018, Lugano, Switzerland
04-05 May 2018, Lugano, Switzerland
27-29 Apr 2018, Lugano, Switzerland
18-22 Apr 2018, Mexico City, Mexico
16-17 Apr 2018, Lugano, Switzerland
13-14 Apr 2018, Lugano, Switzerland
11-14 Apr 2018, Geneva, Switzerland
06-07 Apr 2018, Dubai, United Arab Emirates
24-29 Mar 2018, Nauen OT Groß Behnitz (Berlin area), Germany
23-24 Mar 2018, Barcelona, Spain
16-17 Mar 2018, Hong Kong, Hong Kong
